RVPHW (Reviva Pharmaceuticals Holdings) PB Ratio: (As of Sep. 10, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

RVPHW Reviva Pharmaceuticals Holdings Inc RVPHW
21 GF Score
Price $0.00
! 1 Warning Sign
View Full Analysis

What is Reviva Pharmaceuticals Holdings PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-09-10), Reviva Pharmaceuticals Holdings's share price is $0.003. Reviva Pharmaceuticals Holdings's Book Value per Share for the quarter that ended in Jun. 2026 was $0.00. Hence, Reviva Pharmaceuticals Holdings's PB Ratio of today is .

The historical rank and industry rank for Reviva Pharmaceuticals Holdings's PB Ratio or its related term are showing as below:

RVPHW' s PB Ratio Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0.46
Current: 0.46

During the past 7 years, Reviva Pharmaceuticals Holdings's highest PB Ratio was 0.46. The lowest was 0.00. And the median was 0.00.

RVPHW's PB Ratio is ranked better than
95.39% of 1214 companies
in the Biotechnology industry
Industry Median: 2.915 vs RVPHW: 0.46

During the past 12 months, Reviva Pharmaceuticals Holdings's average Book Value Per Share Growth Rate was 322.10% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -43.60% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -51.50% per year.

During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of Reviva Pharmaceuticals Holdings was -29.80% per year. The lowest was -79.40% per year. And the median was -43.60% per year.

Back to Basics: PB Ratio


Reviva Pharmaceuticals Holdings  (NAS:RVPHW) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Reviva Pharmaceuticals Holdings PB Ratio Related Terms


Reviva Pharmaceuticals Holdings PB Ratio Historical Data

* Premium members only.

The historical data trend for Reviva Pharmaceuticals Holdings's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Reviva Pharmaceuticals Holdings PB Ratio Chart

Reviva Pharmaceuticals Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PB Ratio
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Reviva Pharmaceuticals Holdings Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

RVPHW vs ADTX, DRMA, CLGN: PB Ratio Comparison

For the Biotechnology subindustry, Reviva Pharmaceuticals Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Reviva Pharmaceuticals Holdings PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Reviva Pharmaceuticals Holdings's PB Ratio distribution charts can be found below:

* The bar in red indicates where Reviva Pharmaceuticals Holdings's PB Ratio falls into.


RVPHW
21GF Score
Reviva Pharmaceuticals Holdings Inc RVPHW
PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Reviva Pharmaceuticals Holdings PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Reviva Pharmaceuticals Holdings's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Jun. 2026)
=0.003/0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Reviva Pharmaceuticals Holdings Business Description

Other Exchanges RVPH:USA
Address 10080 North Wolfe Road, Suite SW3-200, Cupertino, CA, USA, 95014
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063), which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis, and its other drug candidate is RP1208.
21GF Score

Get the complete analysis for RVPHW

PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price